Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Jun;3(6):303-5.
doi: 10.1002/emmm.201100137. Epub 2011 May 3.

Beyond the GWAS in schizophrenia

Anil K Malhotra  1
Affiliations
Comment

Beyond the GWAS in schizophrenia

Anil K Malhotra. EMBO Mol Med. 2011 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Translational research approach to cognitive function incorporating cellular, animal and human data
See this image and copyright information in PMC

Comment on

References

    1. Blank T, Nijholt I, Kye MJ, Radulovic J, Spiess J. Small-conductance, Ca2+-activated K+ channel SK3 generates age-related memory and LTP deficits. Nat Neurosci. 2003;6:911–912. - PubMed
    1. Barnett JH, Scoriels L, Munafò MR. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 2008;64:137–144. - PubMed
    1. Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Arnold C, Haddad L, Mier D, Opitz von Boberfeld C, et al. Neural mechanisms of a genome-wide supported psychosis variant. Science. 2009;5927:605. - PubMed
    1. Grube S, Gerchen MF, Adamcio B, Pardo LA, Martin S, Malzahn D, Papiol S, Begemann M, Ribbe K, Friedrichs H, et al. A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med. 2011 this issue; DOI: 10.1002/emmm.201100135. - PMC - PubMed
    1. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007;64:633–647. - PubMed

Substances